Anzeige
Mehr »
Login
Montag, 27.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Silber-Tsunami voraus: Silver Storm als ultimative Investment-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema PLURI INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
20.05.Pluri Inc.: Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale1
09.05.Pluri Inc. - S-8, Securities to be offered to employees in employee benefit plans1
09.05.Pluri Inc. - 10-Q, Quarterly Report2
02.05.Pluri Inc.: Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment137Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical needMAIT...
► Artikel lesen
17.04.Pluri Inc. - 8-K, Current Report1
01.04.Pluri Inc. - 8-K, Current Report2
28.03.Pluri Inc.: Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences4
27.03.Pluri Inc. Announces 1-for-8 Reverse Share Split130HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the "Company"), a leading biotechnology company that transforms cells into solutions, today announced...
► Artikel lesen
21.03.Pluri Inc.: Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report2
19.03.Pluri Inc.: Engage with Pluri's Talent: Exciting Conference Appearances Ahead2
14.03.Pluri Inc.: Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing310HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced...
► Artikel lesen
11.03.Pluri Inc. secures patent for agtech cell expansion1
06.03.Pluri Inc. adds James Roosevelt Jr. to advisory board1
06.03.Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board1
13.02.Pluri Inc. - 8-K, Current Report2
12.02.Pluri Inc. - 10-Q, Quarterly Report3
24.01.Pluri Inc. - 8-K, Current Report2
23.01.Pluri Inc.: Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis5
08.01.Pluri Inc. - 8-K, Current Report1
08.01.Pluri Inc.: Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization404Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division.PluriCDMO...
► Artikel lesen
Seite:  Weiter >>